Verastem (VSTM)
(Delayed Data from NSDQ)
$6.08 USD
-0.09 (-1.46%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.08 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2025
Time: AMC |
6/2025 | $-0.85 | -16.47% |
Earnings Summary
For their last quarter, Verastem (VSTM) reported earnings of -$0.96 per share, missing the Zacks Consensus Estimate of -$0.72 per share. This reflects a negative earnings surprise of 33.33%. Look out for VSTM's next earnings release on August 07, 2025. For the next earning release, we expect the company to report earnings of -$0.85 per share, reflecting a year-over-year decrease of 174.19%.
Earnings History
Price & Consensus
Zacks News for VSTM
Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?
VSTM: What are Zacks experts saying now?
Zacks Private Portfolio Services
VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval
Verastem Oncology to Report Q1 Earnings: What's in the Cards?
Top Cancer Stocks to Buy to Boost Your Portfolio's Health
VSTM FAQs
Verastem, Inc. (VSTM) has announced they will report their next quarter earnings on August 07, 2025. For the next earning release, we expect the company to report earnings of $-0.85 per share, reflecting a year-over-year decrease of -174.19%.
Verastem, Inc. has announced they will report their previous quarter earnings after the close of the market on August 07, 2025.
The Zacks Consensus Estimate for Verastem, Inc. (VSTM) for the quarter ending in June 2025 is $-0.85 a share. We expect Verastem, Inc. to miss by -16.47%.
In the earnings report for the quarter ending in June 2024, Verastem, Inc. (VSTM) announced earnings of $-0.31 per share versus the Zacks Consensus Estimate of $-1.06 per share, representing a surprise of -70.75%.